Michael B. Chancellor

Michael B. Chancellor, MD, is a Professor of Urology at the Oakland University William Beaumont School of Medicine in Michigan, USA. Dr. Chancellor, board certified by the American Board of Urology, received his medical degree from Medical College of Wisconsin. He completed his residency in urology at the University of Michigan. He subsequently completed his fellowship in neurourology and female urology at Columbia University.

Dr. Chancellor is a world-renowned author, speaker, and has been invited to present more than 650 papers at national and international meetings. He has appeared in CNN, Wall Street Journal and numerous television and radio interviews. Dr. Chancellor has written over 550 peer-reviewed articles and book chapters in journals including The Journal of Urology, Urology, Gene Therapy, and Lancet. He has also authored the book Atlas of Urodynamics.

A prolific author and researcher, Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering, drug discovery and he was one of the first urologist to use botulinum toxin to treat lower urinary tract dysfunction. Dr. Chancellor's discovery in cellular therapy has led to multicenter North American trial using adult autologous muscle derived cells to treat stress urinary incontinence. He is also a pioneer in local drug delivery using liposomes to treat bladder diseases. Dr. Chancellor has received a number of prestigious awards, including the Paul Zimkin Award, from The Urodynamics Society, grand prizewinner of the International Jack Lapides Essay Contest and The Pfizer-American Urological Association Visiting Professorship Award. He was recognized as Innovator of the Year by the Pittsburgh Magazine and one of the "Best Doctors in America".

Dr. Chancellor has received funding from the National Institute of Health for over a decade and he has trained many of today's experts in urology.